[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337257-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-337257-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","comprehensive-characterization-of-mcl-1-in-patients-with-colorectal-cancer-expression-molecular-profiles-and-outcomes-cancer-therapy-and-prevention","Comprehensive characterization of MCL-1 in patients with colorectal cancer - Expression, molecular profiles, and outcomes - Cancer Therapy and Prevention","","Myeloid cell leukemia 1 (MCL-1) is an anti-apoptotic BCL-2 family protein whose deregulation contributes to multiple cancers. This study evaluates how MCL-1 expression relates to molecular features, immune infiltration, and clinical outcomes in colorectal cancer. CRC samples analyzed with NextGen DNA sequencing, whole transcriptome sequencing, whole exome sequencing, and IHC were stratified into MCL-1high (Q4) versus MCL-1low (Q1). MCL-1high tumors show increased PD-L1 IHC, stronger T-cell-inflamed and interferon signatures, higher MSI-H and TMB-high status, distinct mutation and copy-number patterns, altered tumor microenvironment infiltration, and significantly favorable clinical outcomes.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/comprehensive-characterization-of-mcl-1-in-patients-with-colorectal-cancer-expression-molecular-profiles-and-outcomes-cancer-therapy-and-prevention/337257/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/comprehensive-characterization-of-mcl-1-in-patients-with-colorectal-cancer-expression-molecular-profiles-and-outcomes-cancer-therapy-and-prevention/337257.png","ImageObject",300,407,{"name":42,"@type":43},"Valentina","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What does the study focus on regarding MCL-1 in colorectal cancer?","Question",{"text":63,"@type":64},"The study examines how MCL-1 expression relates to molecular features, immune cell infiltration in the tumor microenvironment, and patient outcomes in colorectal cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were colorectal cancer samples categorized for analysis?",{"text":68,"@type":64},"CRC samples were stratified by MCL-1 expression into MCL-1high (top quartile, Q4) and MCL-1low (bottom quartile, Q1).",{"name":70,"@type":61,"acceptedAnswer":71},"Which immune and tumor microenvironment signals are linked to higher MCL-1 expression?",{"text":72,"@type":64},"MCL-1high tumors show higher PD-L1 IHC, increased T cell-inflamed signature and interferon score, and higher infiltration of M1/M2 macrophages, B cells, natural killer cells, neutrophils, and T-regulatory cells, with lower myeloid dendritic cell infiltration.",{"name":74,"@type":61,"acceptedAnswer":75},"What is the clinical significance of MCL-1high in the study’s cohorts?",{"text":76,"@type":64},"Higher MCL-1 expression is significantly associated with favorable clinical outcomes, and the data support MCL-1 as a potential modulator of antitumor immunity and biomarker in colorectal cancer.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},337257,1790164402,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,109,114,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":106,"show_sort_weight":107,"slug":108},"Technology",50,"technology",{"id":110,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},7,"Healthcare",40,"healthcare",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},8,30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":115,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":149,"preview_page_count":33,"preview_urls":150},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","DOI: 10.1002/ijc.35304  \nRES EARCH A RTICLE  \nCancer Therapy a nd Prevention  \nComprehensive characterization of MCL-1 in patients with colorectal cancer: Expression, molecular profiles, and outcomes  \nPooja Mittal 1,2  | Francesca Battaglin 1 | Yasmine Baca 3 | Joanne Xiu 3 | Alex Farrell 3 | Shivani Soni 1 | Jae Ho Lo 1 | Lesly Torres-Gonzalez 1 |  \nSandra Algaze 1 | Priya Jayachandran 1 | Karam Ashouri 1 | Alexandra Wong 1 | Wu Zhang 1 | Jian Yu 1 | Lin Zhang 1  | Benjamin A. Weinberg 4 | Emil Lou 5 | Anthony F. Shields 6 | Richard M. Goldberg 7 | John L. Marshall 4 | Sanjay Goel 8 | Indrakant K. Singh 1,2,9  | Heinz-Josef Lenz 1   \n1Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA 2Department of Zoology, Deshbandhu College,  \nUniversity of Delhi, New Delhi, India 3Caris Life Sciences, Phoenix, Arizona, USA 4Ruesch Center for The Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA  \n5Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA 6Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA  \n7West Virginia University Cancer Institute, Morgantown, West Virginia, USA  \n8Robert Wood Johnson Medical School, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA  \n9Delhi School of Public Health, Institute of Eminence, University of Delhi, New Delhi, India  \nCorrespondence  \nHeinz-Josef Lenz, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.  \nEmail: [lenz@med.usc.edu](lenz@med.usc.edu)  \nAbstract  \nMyeloid cell leukemia 1 (MCL-1) is a member of the B-cell lymphoma 2 protein family and has anti-apoptotic functions. Deregulation of MCL-1 has been reported in several cancers, including lung and breast cancer. In the present study, the association of MCL-1 expression with molecular features in colorectal cancer (CRC) has been highlighted. CRC samples from Caris Life Sciences (Phoenix, AZ) were analyzed using NextGen DNA sequencing, whole transcriptome sequencing, whole exome sequencing, and immunohistochemistry (IHC); and stratified based on MCL-1 expression as top quartile MCL-1high (Q4) and bottom quartile MCL-1low (Q1). Immune cell infiltration (CI) in the tumor microenvironment (TME) was measured using RNA deconvolution analysis (QuanTIseq). MCL- 1high tumors were associated with an increased rate of programmed death ligand 1 IHC, higher T cell-inflamed signature, interferon score, microsatellite instability-high and tumor mutational burden-high status. MCL-1high was associated with higher mutation rates of BCOR, TP53, KMT2D, ASXL1, KDM6A, ATM, MSH6, SPEN, KRAS, STK11, GNAS, RNF43, and lower mutation rates of CDKN1B, NRAS, and APC, and copy number amplifications in several genes. MCL-1high TME had higher CI of M1 and M2 macrophages, B cells, natural killer cells, neutrophils, and T-regulatory cells infiltration, and lower CI of myeloid dendritic cells. Higher MCL-1 expression is significantly associated with favorable clinical outcomes in CRC cohorts. Our data showed a strong correlation between MCL-1 and distinct immune biomarkers and TME CI in CRC. Our findings suggest MCL-1 is a potential modulator of antitumor immunity, TME, and biomarker in CRC.  \nIndrakant K. Singh and Heinz-Josef Lenz are co-senior authors.  \nPart of the manuscript is presented in the poster: [https://www.carislifesciences.com/wp-content/uploads/2023/05/ASCO-Caris-2023_Mittal_Characterization-of-MCL-1-in-patients-with](https://www.carislifesciences.com/wp-content/uploads/2023/05/ASCO-Caris-2023_Mittal_Characterization-of-MCL-1-in-patients-with)colorectal-cancer-CRC-Expression-molecular-profiles-and-outcomes. pdf.  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs Licens","cbCaidbSRSMdp3LH","https://ap.wps.com/l/cbCaidbSRSMdp3LH","pdf",2233364,11,"English","# Abstract\n## Methods overview\n## Key associations with MCL-1high\n## Clinical and biological implications","[{\"question\":\"What does the study focus on regarding MCL-1 in colorectal cancer?\",\"answer\":\"The study examines how MCL-1 expression relates to molecular features, immune cell infiltration in the tumor microenvironment, and patient outcomes in colorectal cancer.\"},{\"question\":\"How were colorectal cancer samples categorized for analysis?\",\"answer\":\"CRC samples were stratified by MCL-1 expression into MCL-1high (top quartile, Q4) and MCL-1low (bottom quartile, Q1).\"},{\"question\":\"Which immune and tumor microenvironment signals are linked to higher MCL-1 expression?\",\"answer\":\"MCL-1high tumors show higher PD-L1 IHC, increased T cell-inflamed signature and interferon score, and higher infiltration of M1/M2 macrophages, B cells, natural killer cells, neutrophils, and T-regulatory cells, with lower myeloid dendritic cell infiltration.\"},{\"question\":\"What is the clinical significance of MCL-1high in the study’s cohorts?\",\"answer\":\"Higher MCL-1 expression is significantly associated with favorable clinical outcomes, and the data support MCL-1 as a potential modulator of antitumor immunity and biomarker in colorectal cancer.\"}]","Comprehensive characterization of MCL-1 in patients with colorectal cancer - Expression, molecular profiles, and outcomes - Cancer Therapy and Prevention | PDF",1790018358,28,[151,155,159,163],{"page_no":22,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3485712fa7b0d2583468fd6a3005f283.webp",983,1291,{"page_no":26,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3a4e4443c2f529d6f0399d1a4e691ba0.webp",982,1290,{"page_no":30,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd9b7a6bd992e581dff788829473eb98.webp",981,1289,{"page_no":33,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eaac4bab58d65108176e2be8874d000f.webp",980,1287]